CoChat
Sign Up
Cited by 14

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Caloric restriction rescues yeast cells from alpha-synuclein toxicity through autophagic control of proteostasis

Sampaio-Marques, Belém, Pereira, Hélder, Santos, Ana R., Teixeira, Alexandra, Ludovico, Paula·2018·Aging
DOI 10.18632/aging.101675PMC PMC6326672
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/aging.101675

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Caloric restriction abrogates α-synuclein (SNCA)-induced toxicity by upregulating ubiquitin-proteasome system activity. (A) Chronological lifespan (CLS) and SNCA levels of stationary wild type cells harbouring the vector control or expressing the human SNCA grown under regular (2% glucose) or CR (0.5% glucose) conditions. (B) Chymotrypsin- and trypsin like activities. The assay was normalized to the total protein amount. (C) UPS activity measured by monitoring the ubiquitin/proteasome-dependent proteolysis of the short-lived protein UBG76V-GFP. GFP was detected by Western blotting using a GFP-specific antibody. (D) Graphical representation of GFP/Pgk1 obtained by densitometric analysis. (E) Ubiquitination profile determined by Western blotting using an anti-mono and polyubiquitination antibody. (F) Graphical representation of the intensity of total UB/Pgk1 obtained by densitometric analysis. (G) RPN4 and (H) RPN5 mRNA relative expression levels. Three reference genes (ACT1-actin, PDA1-alpha subunit of pyruvate dehydrogenase and TDH2-isoform 2 of glyceraldehyde-3-phosphate dehydrogenase) were used as internal standards and for the normalization of mRNA expression levels. Significance was determined by two-way ANOVA (*p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001) between cells grown under regular or CR conditions expressing vector control or SNCA. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).
Figure 1 Caloric restriction abrogates α-synuclein (SNCA)-induced toxicity by upregulating ubiquitin-proteasome system activity. (A) Chronological lifespan (CLS) and SNCA levels of stationary wild type cells harbouring the vector control or expressing the human SNCA grown under regular (2% glucose) or CR (0.5% glucose) conditions. (B) Chymotrypsin- and trypsin like activities. The assay was normalized to the total protein amount. (C) UPS activity measured by monitoring the ubiquitin/proteasome-dependent proteolysis of the short-lived protein UBG76V-GFP. GFP was detected by Western blotting using a GFP-specific antibody. (D) Graphical representation of GFP/Pgk1 obtained by densitometric analysis. (E) Ubiquitination profile determined by Western blotting using an anti-mono and polyubiquitination antibody. (F) Graphical representation of the intensity of total UB/Pgk1 obtained by densitometric analysis. (G) RPN4 and (H) RPN5 mRNA relative expression levels. Three reference genes (ACT1-actin, PDA1-alpha subunit of pyruvate dehydrogenase and TDH2-isoform 2 of glyceraldehyde-3-phosphate dehydrogenase) were used as internal standards and for the normalization of mRNA expression levels. Significance was determined by two-way ANOVA (*p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001) between cells grown under regular or CR conditions expressing vector control or SNCA. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).CC BY · PubMed Central
Figure 2 Autophagy inhibition leads to upregulation of the ubiquitin-proteasome system activity in α-synuclein (SNCA)-expressing cells under caloric restriction. (A) Chronological lifespan (CLS) and SNCA levels of SNCA-expressing stationary wild type cells, under caloric restriction (CR, 0.5% glucose) conditions, in the presence or absence of chloroquine (CQ), an inhibitor of autophagy. (B) Mean (50% survival) and maximum (10% survival) lifespans determined from curve fitting of the survival data from CLS. Significance was determined by two-way ANOVA (*p≤0.05, ****p≤0.0001) between cells grown under CR conditions expressing vector control or SNCA in the presence or absence of CQ. (C) RPN4 mRNA relative expression levels as described in the legend of Figure 1. (D) Chymotrypsin- and trypsin like activities. The assay was normalized to the total protein amount. (E) UPS activity measured by monitoring the ubiquitin/proteasome-dependent proteolysis of the short-lived protein UBG76V-GFP. GFP was detected by Western blotting using a GFP-specific antibody. (F) Graphical representation of GFP/Pgk1 obtained by densitometric analysis. (G) Ubiquitination profile determined by Western blotting using an anti-mono and polyubiquitination antibody. (H) Graphical representation of the intensity of total UB/Pgk1 obtained by densitometric analysis. Statistical significance represented in (C), (D), (F) and (H) was determined by Student's t-test (*p≤0.05, ***p≤0.001, ****p≤0.0001) comparing caloric restricted vector control or SNCA-expressing cells in the presence or absence of CQ. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).
Figure 2 Autophagy inhibition leads to upregulation of the ubiquitin-proteasome system activity in α-synuclein (SNCA)-expressing cells under caloric restriction. (A) Chronological lifespan (CLS) and SNCA levels of SNCA-expressing stationary wild type cells, under caloric restriction (CR, 0.5% glucose) conditions, in the presence or absence of chloroquine (CQ), an inhibitor of autophagy. (B) Mean (50% survival) and maximum (10% survival) lifespans determined from curve fitting of the survival data from CLS. Significance was determined by two-way ANOVA (*p≤0.05, ****p≤0.0001) between cells grown under CR conditions expressing vector control or SNCA in the presence or absence of CQ. (C) RPN4 mRNA relative expression levels as described in the legend of Figure 1. (D) Chymotrypsin- and trypsin like activities. The assay was normalized to the total protein amount. (E) UPS activity measured by monitoring the ubiquitin/proteasome-dependent proteolysis of the short-lived protein UBG76V-GFP. GFP was detected by Western blotting using a GFP-specific antibody. (F) Graphical representation of GFP/Pgk1 obtained by densitometric analysis. (G) Ubiquitination profile determined by Western blotting using an anti-mono and polyubiquitination antibody. (H) Graphical representation of the intensity of total UB/Pgk1 obtained by densitometric analysis. Statistical significance represented in (C), (D), (F) and (H) was determined by Student's t-test (*p≤0.05, ***p≤0.001, ****p≤0.0001) comparing caloric restricted vector control or SNCA-expressing cells in the presence or absence of CQ. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).CC BY · PubMed Central
Figure 3 Pharmacological inhibition of the ubiquitin-proteasome system activity decreases lifespan of α-synuclein (SNCA)-expressing cells grown under caloric restriction but has no major impact on autophagy. (A) Chymotrypsin- and trypsin like activities. The assay was normalized to the total protein amount. Significance was determined by two-way ANOVA (*p≤0.05, **p≤0.01, ***p≤0.001) between cells grown under CR (0.5% glucose) conditions expressing vector control or SNCA in the presence or absence of bortezomib (Bort). (B) RPN4 mRNA relative expression levels as described in the legend of Figure 1. (C) UPS activity measured by monitoring the ubiquitin/proteasome-dependent proteolysis of the short-lived protein UBG76V-GFP. GFP was detected by Western blotting using a GFP-specific antibody. (D) Graphical representation of GFP/Pgk1 obtained by densitometric analysis. Statistical significance represented in (B) and (D) was determined by Student's t-test (*p≤0.05, **p≤0.01, ***p≤0.001) comparing caloric restricted vector control or SNCA-expressing cells in the presence or absence of Bort. (E) Chronological lifespan (CLS) and SNCA levels of pdr5Δ cells expressing SNCA grown under CR conditions, in the presence or absence of Bort. (F) Mean (50% survival) and maximum (10% survival) lifespans determined from curve fitting of the survival data from CLS. Significance was determined by two-way ANOVA (***p≤0.001) between cells grown under CR conditions expressing vector control or SNCA in the presence or absence of Bort. Autophagy flux assessed by the GFP-Atg8 processing assay (immunoblotting analysis with antibody against GFP) of caloric restricted cells expressing vector control (G) or SNCA (H) in the absence or presence of Bort. Blots represented in (G) are from the same gel, as in (H). (I) Densitometric analysis of the ratio between the free GFP versus the total GFP. Bands were quantified by Quantity One software. Significance of the data was determined by two-way ANOVA (**p≤0.01, ***p≤0.001, ****p≤0.0001) between cells grown under CR conditions expressing vector control or SNCA in the presence or absence of Bort. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).
Figure 3 Pharmacological inhibition of the ubiquitin-proteasome system activity decreases lifespan of α-synuclein (SNCA)-expressing cells grown under caloric restriction but has no major impact on autophagy. (A) Chymotrypsin- and trypsin like activities. The assay was normalized to the total protein amount. Significance was determined by two-way ANOVA (*p≤0.05, **p≤0.01, ***p≤0.001) between cells grown under CR (0.5% glucose) conditions expressing vector control or SNCA in the presence or absence of bortezomib (Bort). (B) RPN4 mRNA relative expression levels as described in the legend of Figure 1. (C) UPS activity measured by monitoring the ubiquitin/proteasome-dependent proteolysis of the short-lived protein UBG76V-GFP. GFP was detected by Western blotting using a GFP-specific antibody. (D) Graphical representation of GFP/Pgk1 obtained by densitometric analysis. Statistical significance represented in (B) and (D) was determined by Student's t-test (*p≤0.05, **p≤0.01, ***p≤0.001) comparing caloric restricted vector control or SNCA-expressing cells in the presence or absence of Bort. (E) Chronological lifespan (CLS) and SNCA levels of pdr5Δ cells expressing SNCA grown under CR conditions, in the presence or absence of Bort. (F) Mean (50% survival) and maximum (10% survival) lifespans determined from curve fitting of the survival data from CLS. Significance was determined by two-way ANOVA (***p≤0.001) between cells grown under CR conditions expressing vector control or SNCA in the presence or absence of Bort. Autophagy flux assessed by the GFP-Atg8 processing assay (immunoblotting analysis with antibody against GFP) of caloric restricted cells expressing vector control (G) or SNCA (H) in the absence or presence of Bort. Blots represented in (G) are from the same gel, as in (H). (I) Densitometric analysis of the ratio between the free GFP versus the total GFP. Bands were quantified by Quantity One software. Significance of the data was determined by two-way ANOVA (**p≤0.01, ***p≤0.001, ****p≤0.0001) between cells grown under CR conditions expressing vector control or SNCA in the presence or absence of Bort. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).CC BY · PubMed Central
Figure 4 Genetic inhibition of the ubiquitin-proteasome system activity decreases lifespan of α-synuclein (SNCA)-expressing cells grown under caloric restriction conditions but has no major impact on autophagy. Mean (50% survival) and maximum (10% survival) lifespans determined from curve fitting of the survival data from CLS of caloric restricted vector control and SNCA expressing wild type cells compared with RPN4 (A) and UMP1 (B) deleted cells. (C) Autophagy flux assessed by the GFP-Atg8 processing assay (immunoblotting analysis with antibody against GFP) of wild type, rpn4Δ and ump1Δ caloric restricted cells expressing vector control or SNCA. Blots from same strain were run in the same gel. Densitometric analysis of the ratio between the free GFP versus the total GFP of rpn4Δ (D) and ump1Δ (E) cells. Data from wild type cells is repeated in (D) and (E) for easier interpretation. Bands were quantified by Quantity One software. (F) Mean and maximum lifespans determined from curve fitting of the survival data from CLS of wild type and cue5Δ cells expressing the vector control or SNCA in normal (2% glucose) or CR (0.5% glucose) growth conditions. (G) Mean and maximum lifespans determined from curve fitting of the survival data from CLS of wild type cells expressing the vector control or SNCA in the absence or presence of chloroquine (CQ). Significance was determined by Student's t-test (*p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001) comparing wild type with each mutant strain in the same conditions. For (G) the comparison was done between vector control or SNCA-expressing cells in the presence or absence of CQ. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).
Figure 4 Genetic inhibition of the ubiquitin-proteasome system activity decreases lifespan of α-synuclein (SNCA)-expressing cells grown under caloric restriction conditions but has no major impact on autophagy. Mean (50% survival) and maximum (10% survival) lifespans determined from curve fitting of the survival data from CLS of caloric restricted vector control and SNCA expressing wild type cells compared with RPN4 (A) and UMP1 (B) deleted cells. (C) Autophagy flux assessed by the GFP-Atg8 processing assay (immunoblotting analysis with antibody against GFP) of wild type, rpn4Δ and ump1Δ caloric restricted cells expressing vector control or SNCA. Blots from same strain were run in the same gel. Densitometric analysis of the ratio between the free GFP versus the total GFP of rpn4Δ (D) and ump1Δ (E) cells. Data from wild type cells is repeated in (D) and (E) for easier interpretation. Bands were quantified by Quantity One software. (F) Mean and maximum lifespans determined from curve fitting of the survival data from CLS of wild type and cue5Δ cells expressing the vector control or SNCA in normal (2% glucose) or CR (0.5% glucose) growth conditions. (G) Mean and maximum lifespans determined from curve fitting of the survival data from CLS of wild type cells expressing the vector control or SNCA in the absence or presence of chloroquine (CQ). Significance was determined by Student's t-test (*p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001) comparing wild type with each mutant strain in the same conditions. For (G) the comparison was done between vector control or SNCA-expressing cells in the presence or absence of CQ. Data represents mean ± SEM of at least three biological independent replicas. The error bars represent the standard error of the mean (SEM).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 47

  1. Masliah, 2013, The many faces of α-synuclein: from structure and toxicity to therapeutic target., Nat Rev Neurosci, 1, 38, 10.1038/nrn3406 · DOI
  2. Hewitt, 2016, Cellular proteostasis: degradation of misfolded proteins by lysosomes., Essays Biochem, 6, 173, 10.1042/EBC20160005 · DOI
  3. Unni, 2011, Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein., J Neurosci, 3, 14508, 10.1523/JNEUROSCI.1560-11.2011 · DOI
  4. Stefanis, 2013, α-Synuclein and protein degradation systems: a reciprocal relationship., Mol Neurobiol, 4, 537, 10.1007/s12035-012-8341-2 · DOI
  5. Rubinsztein, 2003, Alpha-Synuclein is degraded by both autophagy and the proteasome., J Biol Chem, 27, 25009, 10.1074/jbc.M300227200 · DOI · Paper page
  6. Winderickx, 2005, Characterization of alpha-synuclein aggregation and synergistic toxicity with protein tau in yeast., FEBS J, 27, 1386, 10.1111/j.1742-4658.2005.04571.x · DOI
  7. Paik, 2008, Dequalinium-induced cell death of yeast expressing alpha-synuclein-GFP fusion protein., Neurochem Res, 3, 1393, 10.1007/s11064-008-9598-8 · DOI
  8. Debburman, 2006, alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress., J Mol Neurosci, 2, 161, 10.1385/JMN:28:2:161 · DOI
  9. Braus, 2012, Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome., J Biol Chem, 28, 27567, 10.1074/jbc.M112.361865 · DOI · Paper page
  10. Outeiro, 2014, Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson’s disease., PLoS Genet, 1, e1004302, 10.1371/journal.pgen.1004302 · DOI
  11. Ludovico, 2015, Sirtuins and proteolytic systems: implications for pathogenesis of synucleinopathies., Biomolecules, 5, 735, 10.3390/biom5020735 · DOI
  12. Chu, 2011, Diversity in the regulation of autophagy and mitophagy: lessons from Parkinson’s disease., Parkinsons Dis, 201, 789431, 10.4061/2011/789431 · DOI
  13. Tan, 2007, Role of the ubiquitin proteasome system in Parkinson’s disease., BMC Biochem, 8, S13, 10.1186/1471-2091-8-S1-S13 · DOI
  14. Unni, 2012, Alpha-synuclein’s degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease., Autophagy, 8, 281, 10.4161/auto.8.2.18938 · DOI · Paper page
  15. McLean, 2012, Protein degradation pathways in Parkinson’s disease: curse or blessing., Acta Neuropathol, 12, 153, 10.1007/s00401-012-1004-6 · DOI
  16. Greene, 2001, Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death., J Neurosci, 2, 9549, 10.1523/JNEUROSCI.21-24-09549.2001 · DOI
  17. Grune, 2014, Protein oxidation and proteolytic signalling in aging., Curr Pharm Des, 2, 3040, 10.2174/13816128113196660709 · DOI
  18. Mattson, 1999, Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease., J Neurosci Res, 5, 195, 10.1002/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P · DOI
  19. Sampaio-Marques, 2017, Caloric restriction alleviates alpha-synuclein toxicity in aged yeast cells by controlling the opposite roles of Tor1 and Sir2 on autophagy., Mech Ageing Dev, 16, 270, 10.1016/j.mad.2016.04.006 · DOI · Paper page
  20. Nazir, 2011, Sir-2.1 modulates ‘calorie-restriction-mediated’ prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson’s disease., Biochem Biophys Res Commun, 41, 306, 10.1016/j.bbrc.2011.08.092 · DOI
  21. Mouton, 2004, Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson’s disease., Proc Natl Acad Sci USA, 10, 18171, 10.1073/pnas.0405831102 · DOI
  22. Kanazir, 2007, Dietary restriction modulates alpha-synuclein expression in the aging rat cortex and hippocampus., Synapse, 6, 790, 10.1002/syn.20427 · DOI
  23. Wong, 2006, Increased lifespan in transgenic Caenorhabditis elegans overexpressing human alpha-synuclein., Exp Gerontol, 4, 871, 10.1016/j.exger.2006.05.005 · DOI
  24. Hartl, 2018, Pathways of cellular proteostasis in aging and disease., J Cell Biol, 21, 51, 10.1083/jcb.201709072 · DOI
  25. Kowaltowski, 2011, Aging and calorie restriction modulate yeast redox state, oxidized protein removal, and the ubiquitin-proteasome system., Free Radic Biol Med, 5, 664, 10.1016/j.freeradbiomed.2011.05.035 · DOI
  26. Prolla, 1999, Gene expression profile of aging and its retardation by caloric restriction., Science, 28, 1390, 10.1126/science.285.5432.1390 · DOI · Paper page
  27. Hunter, 2009, A conserved ubiquitination pathway determines longevity in response to diet restriction., Nature, 46, 396, 10.1038/nature08130 · DOI
  28. Karpov, 2008, Rpn4p is a positive and negative transcriptional regulator of the ubiquitin-proteasome system., Mol Biol (Mosk), 4, 518
  29. Keller, 2005, Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability., J Biol Chem, 28, 30009, 10.1074/jbc.M501308200 · DOI
  30. Lee, 2017, Emerging Paradigm of Crosstalk between Autophagy and the Ubiquitin-Proteasome System., Mol Cells, 4, 897, 10.14348/molcells.2017.0226 · DOI
  31. Ludovico, 2012, SNCA (α-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy., Autophagy, 8, 1494, 10.4161/auto.21275 · DOI
  32. Tansey, 2010, Combined chemical and genetic approach to inhibit proteolysis by the proteasome., Yeast, 2, 965, 10.1002/yea.1805 · DOI
  33. Dohmen, 1998, Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly., Cell, 9, 489, 10.1016/S0092-8674(00)80942-3 · DOI
  34. Varshavsky, 2001, RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit., Proc Natl Acad Sci USA, 9, 3056, 10.1073/pnas.071022298 · DOI · Paper page
  35. Vierstra, 2016, Autophagic Turnover of Inactive 26S Proteasomes in Yeast Is Directed by the Ubiquitin Receptor Cue5 and the Hsp42 Chaperone., Cell Reports, 1, 1717, 10.1016/j.celrep.2016.07.015 · DOI
  36. Hochstrasser, 1996, Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly., Cell, 8, 961, 10.1016/S0092-8674(00)80171-3 · DOI
  37. Wolf, 1997, The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing., J Biol Chem, 27, 25200, 10.1074/jbc.272.40.25200 · DOI
  38. Harris, 2009, The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib., Cancer Res, 6, 4415, 10.1158/0008-5472.CAN-08-2839 · DOI
  39. Fan, 2010, Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells., Autophagy, 6, 228, 10.4161/auto.6.2.11042 · DOI
  40. Sagot, 2008, Reversible cytoplasmic localization of the proteasome in quiescent yeast cells., J Cell Biol, 18, 737, 10.1083/jcb.200711154 · DOI
  41. Enenkel, 2015, Intracellular Dynamics of the Ubiquitin-Proteasome-System., F1000 Res, 4, 367, 10.12688/f1000research.6835.1 · DOI
  42. Leu, 2016, Differentiated cytoplasmic granule formation in quiescent and non-quiescent cells upon chronological aging., Microb Cell, 3, 109, 10.15698/mic2016.03.484 · DOI
  43. Enenkel, 2016, Proteasome dynamics between proliferation and quiescence stages of Saccharomyces cerevisiae., Crit Rev Biochem Mol Biol, 5, 497, 10.1080/10409238.2016.1230087 · DOI
  44. Yedidi, 2017, Ubiquitin orchestrates proteasome dynamics between proliferation and quiescence in yeast., Mol Biol Cell, 2, 2479, 10.1091/mbc.e17-03-0162 · DOI
  45. Vierstra, 2018, Proteasome storage granules protect proteasomes from autophagic degradation upon carbon starvation., eLife, 7, 7, 10.7554/eLife.34532 · DOI
  46. Zhang, 2011, An improved method for whole protein extraction from yeast Saccharomyces cerevisiae., Yeast, 2, 795, 10.1002/yea.1905 · DOI
  47. Klionsky, 2008, Biochemical methods to monitor autophagy-related processes in yeast., Methods Enzymol, 45, 1, 10.1016/S0076-6879(08)03201-1 · DOI

Cited by

Sorted by citations

Metadata

Authors
Sampaio-Marques, B., Pereira, H., Santos, A. R., Teixeira, A., & Ludovico, P.
Affiliations
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
Venue
Aging
Publisher
Impact Journals, LLC
Published
2018-12-07
Volume
10
Issue
12
Pages
3821-3833
ISSN
1945-4589
DOI
10.18632/aging.101675
PMC
PMC6326672
Cited by
14
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review